During the past decade, John Mariani conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "John Mariani" are "Benzodiazepine Dependence" (1 trials) and "Opioid Withdrawal" (1 trials). Many other conditions were trialed in "John Mariani" in a lesser frequency.

Most popular intervention types in "John Mariani" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lofexidine 0.18Mg Tab" (1 trials), "Placebo" (1 trials), "Placebo oral tablet" (1 trials), "Pregabalin 200 MG capsules" (1 trials) and "gabapentin" (1 trials). Other intervention names were less common.

The vast majority of trials in "John Mariani" are 2 trials for "All" genders.

Currently, there are NaN active trials in "John Mariani". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in John Mariani, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in John Mariani, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".